Avacta Group Liabilities 2024

Avacta Group Aktienanalyse

What does Avacta Group do?

Avacta Group PLC is a British company specializing in the development of innovative solutions for biotechnology and diagnostics. It was founded in 2004 by Eliot Forster and is headquartered in Wetherby, West Yorkshire. Avacta's history began with the development of Affimer technology, which offers an alternative to conventional antibodies. Affimers are synthetic peptides with high binding affinity to biological molecules, making them important tools for biomedical research and diagnostic applications. The company had limited resources in its early years, and it took several years to complete the development of Affimer technology. In recent years, Avacta has expanded its business model by offering licensed services to pharmaceutical companies. The company provides innovative screening methods and drug discovery tools based on Affimer technology. Avacta has partnerships with major companies such as LG Chem, Moderna, and Wockhardt. The partnership with LG Chem aims to use the platform technology for the development of Covid-19 therapeutics, while the collaboration with Wockhardt focuses on the creation of diagnostic kits and test systems. Avacta's main business areas are biotechnology and diagnostics. The biotechnology division offers screening services for pharmaceutical companies, with a focus on developing higher quality and more efficient antibodies using Affimers, which potentially provide better screening results than traditional antibodies. In the field of diagnostics, the company is working on the development of diagnostic test systems for disease diagnosis. Avacta has started developing diagnostic test kits for Covid-19 that can be used in a laboratory or at home. The company also has a partnership with Adeptrix, a diagnostic tool manufacturing company. Another important area of Avacta is therapeutic applications. Avacta's Affimer technology has already led to new clinical approaches in the development of cancer therapies. Avacta also has a pipeline program of Affimer therapeutics targeting various diseases, from cancer to inflammatory and neurodegenerative diseases. Avacta's products include licensed services for pharmaceutical companies, research kits for Affimer technology, and its own portfolio of Affimer products for various applications in research and diagnostics. The products are exported worldwide, and the company has offices in the United States and South Korea. Overall, Avacta Group PLC has become a major player in the biotechnology and diagnostics industry by expanding its Affimer technology to various applications. Partnerships with major pharmaceutical companies and the development of diagnostic test systems for Covid-19 have brought the company into the public eye and contribute to strengthening its position as a leading provider of Affimer technology in the industry. Avacta Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Avacta Group's Liabilities

Avacta Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Avacta Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Avacta Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Avacta Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Avacta Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Avacta Group stock

What is the level of liabilities of Avacta Group this year?

Avacta Group has a debt balance of 0 GBP this year.

What were the liabilities of Avacta Group compared to the previous year?

The liabilities of Avacta Group have increased by -100% dropped compared to the previous year.

What are the consequences of high debt for investors of Avacta Group?

High liabilities can pose a risk for investors of Avacta Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Avacta Group?

Low liabilities mean that Avacta Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Avacta Group affect the company?

An increase in liabilities of Avacta Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Avacta Group affect the company?

A decrease in the liabilities of Avacta Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Avacta Group?

Some factors that can influence the liabilities of Avacta Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Avacta Group so important for investors?

The liabilities of Avacta Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Avacta Group take to modify the liabilities?

To change its liabilities, Avacta Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Avacta Group pay?

Over the past 12 months, Avacta Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avacta Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Avacta Group?

The current dividend yield of Avacta Group is .

When does Avacta Group pay dividends?

Avacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avacta Group?

Avacta Group paid dividends every year for the past 0 years.

What is the dividend of Avacta Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avacta Group located?

Avacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avacta Group from 11/19/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Avacta Group pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Avacta Group in the year 2023?

In the year 2023, Avacta Group distributed 0 GBP as dividends.

In which currency does Avacta Group pay out the dividend?

The dividends of Avacta Group are distributed in GBP.